nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
American College of Chest Physicians (CHEST) 2022 Annual Meeting
|
Venkatesan, Priya |
|
|
10 |
12 |
p. e113-e114 |
artikel |
2 |
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
|
Vlaar, Alexander P J |
|
|
10 |
12 |
p. 1137-1146 |
artikel |
3 |
Chronic cough and cough hypersensitivity: from mechanistic insights to novel antitussives
|
Mazzone, Stuart B |
|
|
10 |
12 |
p. 1113-1115 |
artikel |
4 |
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
|
Eikelboom, John W |
|
|
10 |
12 |
p. 1160-1168 |
artikel |
5 |
Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
|
Eikelboom, John W |
|
|
10 |
12 |
p. 1169-1177 |
artikel |
6 |
Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?
|
Kalil, Andre C |
|
|
10 |
12 |
p. 1103-1104 |
artikel |
7 |
COP27 Climate Change Conference: urgent action needed for Africa and the world
|
Atwoli, Lukoye |
|
|
10 |
12 |
p. 1115-1117 |
artikel |
8 |
Correction to Lancet Respir Med 2022; 10: 972–84
|
|
|
|
10 |
12 |
p. e116 |
artikel |
9 |
Correction to Lancet Respir Med 2022; 10: 700–14
|
|
|
|
10 |
12 |
p. e116 |
artikel |
10 |
Correction to Lancet Respir Med 2022; published online July 27. https://doi.org/10.1016/S2213-2600(22)00185-0
|
|
|
|
10 |
12 |
p. e116 |
artikel |
11 |
COVID-19: ACT trials for colchicine and antithrombotic therapies
|
Barco, Stefano |
|
|
10 |
12 |
p. 1106-1108 |
artikel |
12 |
COVID-19-related acute respiratory distress syndrome: lessons learned during the pandemic
|
Schultz, Marcus J |
|
|
10 |
12 |
p. 1108-1110 |
artikel |
13 |
Cystic fibrosis treatment: hope for all?
|
The Lancet Respiratory Medicine, |
|
|
10 |
12 |
p. 1099 |
artikel |
14 |
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial
|
Keir, Holly R |
|
|
10 |
12 |
p. 1119-1128 |
artikel |
15 |
Is neutrophilic inflammation treatable in COVID-19?
|
Conrad, Catharina |
|
|
10 |
12 |
p. 1100-1101 |
artikel |
16 |
Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study
|
Feys, Simon |
|
|
10 |
12 |
p. 1147-1159 |
artikel |
17 |
Moving the pathway goalposts: COPD as an immune-mediated inflammatory disease
|
Cass, Steven P |
|
|
10 |
12 |
p. 1110-1113 |
artikel |
18 |
Omicron in pregnancy: time to breathe easier?
|
Auger, Nathalie |
|
|
10 |
12 |
p. 1101-1102 |
artikel |
19 |
Opioid use and sleep apnoea
|
Burki, Talha |
|
|
10 |
12 |
p. 1118 |
artikel |
20 |
Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study
|
Stock, Sarah J |
|
|
10 |
12 |
p. 1129-1136 |
artikel |
21 |
Respiratory system mechanics, gas exchange, and outcomes in mechanically ventilated patients with COVID-19-related acute respiratory distress syndrome: a systematic review and meta-analysis
|
Reddy, Mallikarjuna Ponnapa |
|
|
10 |
12 |
p. 1178-1188 |
artikel |
22 |
Standardising corticosteroid use in acute respiratory distress syndrome
|
Lemieux, Steven M |
|
|
10 |
12 |
p. e109 |
artikel |
23 |
Standards for assessing and reporting adverse events
|
Kawakami, Takashi |
|
|
10 |
12 |
p. e110-e111 |
artikel |
24 |
The approach to informed consent in acute care research
|
Dal-Ré, Rafael |
|
|
10 |
12 |
p. e107 |
artikel |
25 |
The approach to informed consent in acute care research – Authors' reply
|
Casey, Jonathan D |
|
|
10 |
12 |
p. e108 |
artikel |
26 |
The Global Allergy Symposium: environmental causes of allergic disease and effective interventions
|
Ashley-Norman, Phoebe |
|
|
10 |
12 |
p. e115 |
artikel |
27 |
Tuberculosis control: getting back on track in the era of COVID-19
|
Burki, Talha |
|
|
10 |
12 |
p. e112 |
artikel |
28 |
When disaster strikes fungi take control
|
Hoenigl, Martin |
|
|
10 |
12 |
p. 1104-1106 |
artikel |